FDA.reportPublic FDA data

fluticasone furoate 50 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT

RxCUI
2045377
RxNorm name
fluticasone furoate 50 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT
Display name
fluticasone furoate 50 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT
Full name
fluticasone furoate 50 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Fluticasone Furoate ElliptaFLUTICASONE FUROATEPrasco Laboratoriesd3e797fc-2636-49a0-b89e-5246b18ee4402025-03-06Warnings, Adverse reactionsExact identifier
rxcui: 2045377
Arnuity ElliptaFLUTICASONE FUROATEGlaxoSmithKline LLC50f193ee-1691-486d-9370-a664df63695c2023-10-18Warnings, Adverse reactionsExact identifier
rxcui: 2045377

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
50f193ee-1691-486d-9370-a664df63695cfluticasone furoate 50 MCG/ACTUAT Dry Powder Inhaler, 30 Blisters [PSN] · 30 ACTUAT fluticasone furoate 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone furoate 50 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT [SY]317These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
d3e797fc-2636-49a0-b89e-5246b18ee440fluticasone furoate 50 MCG/ACTUAT Dry Powder Inhaler, 30 Blisters [PSN] · 30 ACTUAT fluticasone furoate 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone furoate 50 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT [SY]32These highlights do not include all the information needed to use Fluticasone Furoate ELLIPTA safely and effectively. See full prescribing information for Fluticasone Furoate ELLIPTA. Fluticasone Furoate ELLIPTA inhalation powder, for oral inhalation use Initial U.S. Approval: 201420250306